NDC 67877-676
Deferasirox oral
Deferasirox Oral
Deferasirox oral is a Oral Granule in the Human Prescription Drug category. It is labeled and distributed by Ascend Laboratories, Llc. The primary component is Deferasirox.
| Product ID | 67877-676_09ff4b6e-8868-4f09-ac63-8b1889c3055e |
| NDC | 67877-676 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Deferasirox oral |
| Generic Name | Deferasirox Oral |
| Dosage Form | Granule |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-07-16 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA213374 |
| Labeler Name | Ascend Laboratories, LLC |
| Substance Name | DEFERASIROX |
| Active Ingredient Strength | 180 mg/1 |
| Pharm Classes | Iron Chelating Activity [MoA],Iron Chelator [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Cytochrome P450 1A2 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |